Lanean...
An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy
Background C3 glomerulopathy (C3G) is associated with dysregulation of the alternative pathway of complement activation, and treatment options for C3G remain limited. Complement factor H (FH) is a potent regulator of the alternative pathway and might offer a solution, but the mass and complexity of...
Gorde:
| Argitaratua izan da: | J Am Soc Nephrol |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society of Nephrology
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6054357/ https://ncbi.nlm.nih.gov/pubmed/29588430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2017091006 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|